Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Halmstad – page 2

21 clinical trials in Halmstad, Sweden. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Halmstad at a glance
21
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

21 trials in Halmstad

Open in trial search

Obesity

Not recruiting

Study on Maintaining Weight Loss in Teens with Obesity Using Semaglutide

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Mantle cell lymphoma

Not recruiting

Study of Acalabrutinib and Rituximab for Elderly Patients with Untreated Mantle Cell Lymphoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Region Skane

Mantle cell lymphoma

Not recruiting

Study Comparing Rituximab with Ibrutinib to Rituximab with Chemotherapy for Older Patients with Untreated Mantle Cell Lymphoma

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Region Skane

Study on the Safety and Effectiveness of Adding Hydroxycarbamide to Standard Treatment with Cytarabine and Daunorubicin for Adults with Newly Diagnosed Acute Myeloid Leukemia

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Karolinska University Hospital

Migraine+1

Not recruiting

Study of Eptinezumab as Add-on Treatment for Prevention of Migraine in Adults with Both Migraine and Medication Overuse Headache

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Eptinezumab
  • Sponsor:H. Lundbeck A/S

Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Ibrutinib
  • Sponsor:University Of Cologne

Study on Frexalimab for Preserving Insulin Production in Newly Diagnosed Type 1 Diabetes Patients Aged 12-21 on Insulin Therapy

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years · 18–64 years
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Obesity+1

Not recruiting

Study on the Effects of Semaglutide for Weight Management in Children and Adolescents with Obesity or Overweight

Registered drug
Countries:SwedenSweden
  • Participants:0–17 years
  • Substances:Semaglutide
  • Sponsor:Novo Nordisk A/S

Major depression

Not recruiting

Study on Aticaprant for Adults with Major Depressive Disorder and Anhedonia Not Responding to Antidepressants

Investigational
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Aticaprant
  • Sponsor:Janssen Cilag International

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Halmstad

What the registry says about research in the country

01 Oncology & Hematology

Innovative research focusing on chronic lymphocytic leukemia and mantle cell lymphoma, evaluating various treatment combinations and their effectiveness. Studies include investigations into pediatric cancer immunity and response to vaccinations.

  • Leukemia Treatment Protocols
  • Lymphoma Management
  • Pediatric Cancer Care

Additional research includes HPV vaccination strategies for cervical cancer prevention.

02 Metabolic & Endocrine Disorders

Clinical trials addressing obesity management in children and adolescents, with particular focus on weight maintenance strategies using innovative treatments. Studies also examine Type 1 diabetes management in young patients.

  • Pediatric Weight Management
  • Diabetes Treatment
  • Endocrine Therapies

Research emphasizes long-term effectiveness and safety in young populations.

03 Women's Health & Obstetrics

Studies exploring labor induction methods and post-cesarean pain management. Research includes innovative approaches to outpatient care and analgesic protocols.

  • Labor Management
  • Post-operative Pain Control
  • Maternal Care Optimization

Focus on improving patient outcomes and healthcare delivery methods.

04 Chronic Conditions

Research addressing kidney disease, migraine management, and treatment of resistant infections. Studies evaluate new therapeutic approaches for complex medical conditions.

  • Renal Dialysis Innovation
  • Headache Prevention
  • Antibiotic Resistance

Emphasis on improving quality of life and treatment outcomes.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.